Fig. 5

Viral shedding during the post-challenge phase. Viral shedding was assessed from nasal washings performed daily in the different groups (blue: group 1 – Leucofeligen™ FeLV/RCP, n = 10; green: group 2 – Purevax™ RCP FeLV, n = 10 and black: group 3 – control, n = 9). Data are presented as mean and SD (error bars). Statistically significant differences between groups were observed and are annotated as in Fig. 1